LPAR5 promotes thyroid carcinoma cell proliferation and migration by activating class IA PI3K catalytic subunit p110β

Lysophosphatidic acid receptor 5 (LPAR5) is involved in mediating thyroid cancer progression, but the underlying mechanism needs to be further revealed. In this study, we confirmed that LPAR5 is upregulated in papillary thyroid carcinoma (PTC), especially in BRAF‐like PTC, by analyzing The Cancer Ge...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Zhao, Wei‐Jun, Zhu, Liu‐Lian, Yang, Wei‐Qiang, Xu, Shuai‐Jun, Chen, Jie, Ding, Xiao‐Fei, Liang, Yong, Chen, Guang
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
ORIGINAL ARTICLES
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8019227/
https://ncbi.nlm.nih.gov/pubmed/33540491
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14837
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados